Midgard Science

Nuvisan

Neu-Ulm, Germany nuvisan.com

From their website, Nov 2026

Work here? Claim this listing

About

Nuvisan provides contract research and development services for drug discovery, preclinical development, clinical trials, and clinical trial supply. It serves pharmaceutical and biotech clients from sites in Germany, France, and India.

Services

  • Omics and biomarkers

    Supports target identification and validation, mode-of-action studies, compound profiling, and pharmacodynamic and predictive biomarker discovery.

    Assays & in vitro testing

  • Functional genomics and next-generation sequencing

    Provides CRISPR/Cas9, RNA interference, NGS, single-cell sequencing, and bioinformatics for functional studies and target discovery.

  • Biosciences

    Offers protein production, biochemical assays, cell-based assays, high-content analysis, biophysics, mass spectrometry, and structural biology support for hit identification and characterisation.

    Assays & in vitro testing

  • Compound screening

    Runs high-throughput screening to identify first hits against client-specific targets and mechanisms.

    Assays & in vitro testing

  • Pharmacology

    Delivers in vivo pharmacology models to generate efficacy and safety data for drug development.

    Assays & in vitro testing

  • Chemistry

    Supports hit-to-lead, lead optimisation, scale-up, biotransformations, and physicochemical characterisation.

  • Development DMPK

    Provides in vitro and in vivo DMPK and ADME services, metabolite identification, isotope chemistry, and bioanalysis.

    ADME, DMPK & toxicology

  • In vitro DMPK

    Performs assays for metabolic stability, drug-drug interactions, metabolite identification, permeability and transporters, and protein binding.

    ADME, DMPK & toxicology

  • Metabolite ID

    Conducts cross-species metabolism and in vivo metabolite profiling and structure elucidation.

    ADME, DMPK & toxicology

  • Preclinical development

    Combines scale-up, formulation development, bioanalysis, DMPK, and toxicology testing to bridge discovery and clinical stages.

    ADME, DMPK & toxicology

  • Clinical services phase 1-2

    Provides phase 1 and 2 clinical trial services including clinical pharmacology, multicentre studies, medical and regulatory consulting, data management, biostatistics, and safety support.

  • Clinical pharmacology unit

    Conducts early phase studies such as FIH, SAD/MAD, PoC, DDI, food effect, BA/BE, PK/PD, and special population studies.

  • Clinical laboratory

    Performs clinical safety laboratory analyses using CE-certified tests and sample barcoding.

    Assays & in vitro testing

  • Clinical trial supply services

    Manages manufacturing, packaging, labelling, randomisation, analytical testing, logistics, storage, distribution, and QP release for clinical supplies.

  • Manufacturing of IMP

    Develops and manufactures investigational medicinal products including capsules, powders, liquid formulations, and semi-solid formulations.

    CDMO: development & manufacturing

  • Digital science technologies

    Provides electronic lab notebook, LIMS, compound registration, assay data management, reporting, and data lifecycle tools.

  • Cheminformatics and machine learning

    Develops predictive ML models, quantitative SAR models, and de novo generative chemistry tools for drug discovery.

  • Discovery services

    Supports target understanding, target identification and validation, omics and biomarkers, biosciences, compound screening, pharmacology, chemistry, and discovery DMPK.

    Assays & in vitro testing

  • Pharmaceutical analytical services

    Provides analytical support for small and large molecules, including method development and validation, quality control, stability studies, EU re-testing, and commercial release.

    Assays & in vitro testing

  • Drug substances

    Supports drug substance development and related CMC work within integrated solutions.

  • Drug products

    Supports drug product development and related CMC work within integrated solutions.

  • Bioanalysis

    Provides bioanalytical support in preclinical and clinical development.

    Assays & in vitro testing

  • Biomarkers

    Provides biomarker services within discovery and clinical workflows.

    Assays & in vitro testing

What to send
Sample barcoding

Capabilities

Assays and studies
Bioanalysis · Stability studies · CRISPR · ADME · Toxicology · In vivo · HTS · Small molecules · High-throughput screening · Biochemical assays · Cell-based assays · High-content assays
15 moreBiophysics assays · Protein binding assays · Drug-drug interaction assays · Metabolic stability assays · Permeability assays · Transporter assays · Metabolite identification · In vivo efficacy studies · PK/PD studies · Clinical safety lab analyses · Fragment screening · Virtual screening · Biophysical analyses · Structure-based design · CRISPR/Cas9
Scale and capacity
40 high-monitoring beds · 60 overnight beds · Up to 100 L fermenters · 4-16 L wave bioreactors · Semi-solid clinical batches up to 50 kg · Proprietary small molecule library up to 3 million compounds · More than 5.000 m² GMP facilities · More than 320 m² of stability storage · Six full-time qualified persons
Therapeutic areas
Oncology · Dermatology

Instruments and platforms

  • 10x Genomics
  • ClinSpark
  • ÄKTA
  • SPR
  • MST
  • ITC
  • NMR
  • nanoDSF
  • TSA
  • SEC-MALS
  • DLS
  • F-SEC
  • Flow cytometry
  • MS
  • HR-MS
  • Electronic lab notebook
  • LIMS

Modalities and species

Modalities
Small molecule · Antibody · ADC · Peptide · Gene editing · Recombinant protein · Vaccine · Biosimilar
Species and models
Rodent · Non-rodent species · Healthy volunteers · Special populations · Patients · iPSC-derived cells · Primary cells · Cell lines · E. coli · Insect cells · Mammalian cells · CHO
5 moreHEK293 · Expi293F · Tni · Tumour-bearing animal models · In vivo models

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • GLPSelf-reported

    Scope: laboratories

Company

Type
CRDMO
Team
More than 100 analytical experts across Europe

Locations

Address
Wegenerstrasse 13 89231 Neu-Ulm Germany Berlin Muellerstrasse 178 13353 Berli
Sites
Neu-Ulm, Germany · Berlin, Germany · Sophia Antipolis, France · Grafing, Germany · Waltrop, Germany · Hyderabad, India
Serves
global, worldwide, Europe

Public records

Parent company
Nuvisan ICB GmbH · DE GLEIF
FDA drug establishment registration
3002809479 · ANALYSIS source

Similar labs

Work here? Claim this listing